Subcellular compartmentalization of TNF receptor-1 and CD95 signaling pathways

European Journal of Cell Biology

Volumn 90, Issue 6-7, 2011, Pages 467-475

  Tchikov, Vladimir ^a   Bertsch, Uwe ^a   Fritsch, Jürgen ^a   Edelmann, Bärbel ^a   Schütze, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Apoptosis; Caspase; Cathepsin D; CD95; Ceramide; Sphingomyelinase; TNF; TNF receptosomes; TRAIL

Indexed keywords

CATHEPSIN D; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RIBOFLAVIN KINASE; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR RECEPTOR 1; UBIQUITIN PROTEIN LIGASE; VIRUS PROTEIN;

CELL COMPARTMENTALIZATION; CELL DEATH; CYTOPLASM; GOLGI COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; HUMANS; RECEPTORS, DEATH DOMAIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 79955479863     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2010.11.002     Document Type: Short Survey

References (74)

1. Ahn J.H., Park S.M., Cho H.S., Lee M.S., Yoon J.B., Vilcek J., Lee T.H. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J. Biol. Chem. 2001, 276:47100-47106.
2. Akazawa Y., Mott J.L., Bronk S.F., Werneburg N.W., Kahraman A., Guicciardi M.E., Meng X.W., Khono S., Shah V.H., Kaufmann S.H., McNiven M.A., Gores G.J. Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL im malignant liver cell lines. Gastroenterology 2009, 136:2365-2376.
3. Algeciras-Schimnich A., Shen L., Barnhart B.C., Murmann A.E., Burkhardt J.K., Peter M.E. Molecular ordering of the initial signaling events of CD95. Mol. Cell Biol. 2002, 22:207-220.
4. Austin C.D., Lawrence D.A., Peden A.A., Varfolomeev E.E., Totpal K., De Maziere A.M., Klumperman J., Arnott D., Pham V., Scheller R.H., Ashkenazi A. Death-receptor activation halts clathrin-dependent endocytosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10283-10288.
5. Barnhart B.C., Alappat E.C., Peter M.E. The CD95 type I/type II model. Semin. Immunol. 2003, 15:185-193.
6. Barnhart B.C., Legembre P., Pietras E., Bubici C., Franzoso G., Peter M.E. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J. 2004, 23:3175-3185.
7. Benedict C.A., Norris P.S., Prigozy T.I., Bodmer J.L., Mahr J.A., Garnett C.T., Martinon F., Tschopp J., Gooding L.R., Ware C.F. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol. Chem. 2001, 276:3270-3278.
8. Benedict C.A., Banks T.A., Ware C.F. Death and survival: viral regulation of TNF signaling pathways. Curr. Opin. Immunol. 2003, 15:59-65.
9. Bradley J.R., Johnson D.R., Pober J.S. Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. J. Immunol. 1993, 150:5544-5555.
10. Brenner B., Ferlinz K., Grassme H., Weller M., Koppenhoefer U., Dichgans J., Sandhoff K., Lang F., Gulbins E. Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ. 1998, 5:29-37.
11. Chakrabandhu K., Herincs Z., Huault S., Dost B., Peng L., Conchonaud F., Marguet D., He H.T., Hueber A.O. Palmitoylation is required for efficient Fas cell death signaling. EMBO J. 2007, 26:209-220.
12. Chakrabandhu K., Huault S., Garmy N., Fantini J., Stebe E., Mailfert S., Marguet D., Hueber A.O. The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of sigbals upon activationby ligand. Cell Death Differ. 2008, 15:1824-1837.
13. Cifone M.G., De Maria R., Roncaioli P., Rippo M.R., Azuma M., Lanier L.L., Santoni A., Testi R. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 1994, 180:1547-1552.
14. De Maria R., Rippo M.R., Schuchman E.H., Testi R. Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J. Exp. Med. 1998, 187:897-902.
15. Dumitru C.A., Gulbins E. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 2006, 25:5612-5625.
16. Edelmann, B., Bertsch, U., Tchikov, V., Winoto-Morbach, S., Jakob, M., Perrotta, C., Adam-Klages, S., Kabelitz, D., Schütze, S., 2010. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1-receptosomes. EMBO J. (in press).
17. Feig C., Tchikov V., Schütze S., Peter M.E. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J. 2007, 26:221-231.
18. Fischer R., Maier O., Naumer M., Krippner-Heidenreich A., Scheurich P., Pfizenmaier K. Cell. Signal. 2010, 10.1016/j.cellsig.2010.08.016.
19. Garcia-Ruiz C., Colell A., Mari M., Morales A., Calvo M., Enrich C., Fernandez-Checa J.C. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J. Clin. Invest. 2003, 111:197-208.
20. Glebov O.O., Bright N.A., Nichols B.J. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 2006, 8:46-54.
21. Golks A., Brenner D., Krammer P.H., Lavrik I.N. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J. Exp. Med. 2006, 203:1295-1305.
22. Guicciardi M.E., Gores G.J. Life and death by death receptors. FASEB J. 2009, 23:1625-1637.
23. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008, 9:139-150.
24. Heinrich M., Wickel M., Schneider-Brachert W., Sandberg C., Gahr J., Schwandner R., Weber T., Saftig P., Peters C., Brunner J., Krönke M., Schütze S. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 1999, 18:5252-5263.
25. Heinrich M., Neumeyer J., Jakob M., Hallas C., Tchikov V., Winoto-Morbach S., Wickel M., Schneider-Brachert W., Trauzold A., Hethke A., Schütze S. Cathepsin D links TNF-induced acid sphingomyelinase to bid-mediated caspase-9 and -3 activation. Cell Death Differ. 2004, 11:550-563.
26. Herr I., Wilhelm D., Bohler T., Angel P., Debatin K.M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 1997, 16:6200-6208.
27. Horton T.M., Ranheim T.S., Aquino L., Kusher D.I., Saha S.K., Ware C.F., Wold W.S., Gooding L.R. Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J. Virol. 1991, 65:2629-2639.
28. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996, 4:387-396.
29. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996, 84:299-308.
30. Jenkins R.W., Canals D., Hannun Y.A. Roles and regulation of secretory and lysosomal acis sphingomyelinase. Cell. Signal. 2009, 21:836-846.
31. Kataoka T., Budd R.C., Holler N., Thome M., Martinon F., Irmler M., Burns K., Hahne M., Kennedy N., Kovacsovics M., Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol. 2000, 10:640-648.
32. Kohlhaas S.L., Craxton A., Sun X.M., Pinkoski M.J., Cohen G.M. Receptor-mediated endocytosis is not required for TRAIL-induced apoptosis. J. Biol. Chem. 2007, 282:12831-12841.
33. Koncz G., Kerekes K., Chakrabandhu K., Hueber A.O. Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling. Cell Death Differ. 2007, 15:494-503.
34. Kull F.C., Cuatrecasas P. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res. 1981, 41:4885-4890.
35. Lajoie P., Nabi I.R. Regulation of raft-dependent endocytosis. J. Cell Mol. Med. 2007, 11:644-653.
36. Le Roy C., Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 2005, 6:112-126.
37. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schütze S., Peter M.E., Chan A.C. The role of receptor internalization in CD95 signaling. EMBO J. 2006, 24:1009-1023.
38. Legler D.F., Micheau O., Doucey M.A., Tschopp J., Bron C. Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNF alpha-mediated NF-kappaB activation. Immunity 2003, 18:655-664.
39. Lemke J., Noack A., Adam D., Tchikov V., Bertsch U., Röder C., Schütze S., Wajant H., Kalthoff H., Trauzold A. TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5. J. Mol. Med. 2010, 88:729-740.
40. Liao W., Xiao Q., Tchikov V., Fujita K., Yang W., Wincovitch S., Garfield S., Conze D., El-Deiry W.S., Schütze S., Srinivasula S.M. CARP-2 is an endosome-associated ubiquitin protein ligase for RIP and regulates TNF-induced NF-B activation. Curr. Biol. 2008, 18:641-649.
41. Liao W., Xiao Q., Fujita K., Tchikov V., Yang W., Gunsor M., Garfield S., Goldsmith P., El-Deiry W., Schütze S., Srinivasula S.M. CARP-1 regulates TNF-induced NF-κB activation by targeting RIP for proteasomal degradation. Curr. Biol. 2008, 19:R17-R19.
42. Lichtenstein D.L., Toth K., Doronin K., Tollefson A.E., Wold W.S. Functions and mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 2004, 23:75-111.
43. Lin T., Genestier L., Pinkoski M.J., Castro A., Nicholas S., Mogil R., Paris F., Fuks Z., Schuchman E.H., Kolesnick R.N., Green D.R. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J. Biol. Chem. 2000, 275:8657-8663.
44. Mahul-Mellier A.L., Strappazzone F., Petiot A., Chatellerd-Causse C., Torch S., Blot B., Freeman K., Kuhn L., Garin J., Verna J.M., Fraboulet S., Sadoul R. Alix and ALG-2 are involved in tumor necrosis factor receptor 1-induced cell death. J. Biol. Chem. 2008, 283:34954-34965.
45. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 2007, 8:603-612.
46. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
47. Mirghomizadeh F., Winoto-Morbach S., Orinska Z., Lee K.H., Schütze S., Bulfone-Paus S. Intracellular IL-15 controls mast cell survival. Exp. Cell Res. 2009, 315:3064-3075.
48. Monney L., Olivier R., Otter I., Jansen B., Poirier G.G., Borner C. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 1998, 251:295-303.
49. Morales A., Lee H., Goni F.M., Kolesnick R., Fernandez-Checa J.C. Sphingolipids and cell death. Apoptosis 2007, 12:923-939.
50. Mosselmans R., Hepburn A., Dumont J.E., Fiers W., Galand P. Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J. Immunol. 1988, 141:3096-3100.
51. Neumeyer J., Hallas C., Merkel O., Winoto-Morbach S., Jakob M., Thon L., Adam D., Schneider-Brachert W., Schütze S. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase. Exp. Cell Res. 2006, 312:2142-2153.
52. Parlato S., Giammarioli A.M., Logozzi M., Lozupone F., Matarrese P., Luciani F., Falchi M., Malorni W., Fais S. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 2000, 19:5123-5134.
53. Parton R.G., Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 2007, 8:185-194.
54. Pastorino J.G., Simbula G., Yamamoto K., Glascott P.A., Rothman R.J., Farber J.L. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 1996, 271:29792-29798.
55. Philipp S., Puchert M., Adam-Klages S., Tchikov V., Winoto-Morbach S., Mathieu S., Jung A., Kolker L., Marchesini N., Kabelitz D., Schütze S., Adam D. The polycomb group protein EED couples TNF-receptor 1 to neutral sphingomyelinase. Proc. Natl. Acad. Sci. 2010, 107:1112-1117.
56. Rahman M.M., McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS. Pathog. 2006, 2:e4.
57. Rossin A., Kral R., Lounnas N., Chakrabandhu K., Mailfert S., Marguet D., Hueber A.O. Identification of a lysin-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. Exp. Cell Res. 2010, 316:1513-1522.
58. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998, 17:1675-1687.
59. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., Schütze S. Compartmentalization of TNF receptor 1 signaling; internalized TNF receptosomes as death signaling vesicles. Immunity 2004, 21:415-428.
60. Schneider-Brachert W., Tchikov V., Merkel O., Jakob M., Hallas C., Kruse M.L., Groitl P., Lehn A., Hildt E., Held-Feindt J., Dobner T., Kabelitz D., Krönke M., Schütze S. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J. Clin. Invest. 2006, 116:2901-2913.
61. Schütze S., Tchikov V. Immunomagnetic isolation of TNF receptosomes. Meth. Enzymol. 2008, 442:101-123.
62. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Krönke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992, 71:765-776.
63. Schütze S., Machleidt T., Adam D., Schwandner R., Wiegmann K., Kruse M.L., Heinrich M., Wickel M., Krönke M. Inhibition of receptor internalization by monoadnsylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 1999, 274:10203-10212.
64. Schwandner R., Wiegmann K., Bernardo K., Kreder D., Krönke M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 1998, 273:5916-5922.
65. Smotrys J.E., Linder M.E. Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 2004, 73:559-587.
66. Sorkin A., von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 2009, 10:609-622.
67. Tchikov V., Fritsch J., Kabelitz D., Schütze S. Immunomagnetic isolation of subcellular compartments. Meth. Microbiol. 2010, 37:21-33.
68. Thon L., Mathieu S., Kabelitz D., Adam D. The murine TRAIL receptor signals caspase-independent cell death through ceramide. Exp. Cell Res. 2006, 312:3808-3821.
69. Torres V.A., Mielgo A., Barila D., Anderson D.H., Stupack D. Caspase-8 promotes peripheral localization and activation of RAb5. J. Biol. Chem. 2008, 283:36280-36289.
70. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65.
71. Wiegmann K., Schütze S., Machleidt T., Witte D., Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994, 78:1005-1015.
72. Wiegmann K., Schwandner R., Krut O., Yeh W.C., Mak T.W., Krönke M. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. J. Biol. Chem. 1999, 274:5267-5270.
73. Woo C.H., Kim T.H., Choi J.A., Ryu H.C., Lee J.E., You H.J., Bae Y.S., Kim J.H. Inhibition of receptor internalization attenuates the TNFalpha-induced ROS generation in non-phagocytic cells. Biochem. Biophys. Res. Commun. 2006, 351:972-978.
74. Yazdanpanah B., Wiegmann K., Tchikov V., Pongratz C., Kleinridders A., Kashkar H., Krut O., Brüning J.C., Schütze S., Krönke M. Ribovlavin kinase couples TNF receptor 1 to p22phox. Nature 2009, 460:1159-1163.